Synthesis and PI3 Kinase Inhibition Activity of a Wortmannin-Leucine Derivative

Wortmannin is a potent covalent inhibitor of PI3K that shows substantial in vivo toxicity and thus is unsuitable for systemic therapeutic applications. One possible approach to minimize systemic toxicity is to generate a latent wortmannin pro-drug that will be selectively activated in target tissues...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantrell, William, Huang, Yue, Menchaca, Antonio A., Kulik, George, Welker, Mark E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100554/
https://www.ncbi.nlm.nih.gov/pubmed/30036994
http://dx.doi.org/10.3390/molecules23071791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100554/
https://www.ncbi.nlm.nih.gov/pubmed/30036994
http://dx.doi.org/10.3390/molecules23071791

Ejemplares similares